Healthcare Supply Chain Partner Evaluation Scorecard
Why a Scorecard
Selecting an in-market supply chain and commercialization partner is among the highest-consequence decisions in a
market-entry program. The partner will hold your product, your registrations, your inventory, and — under a 4PL model — your customer relationships and receivables. Yet these decisions are too often made on the basis of price and rapport rather than structured capability.
This scorecard imposes structure. It evaluates partners across
seven weighted dimensions , with the weighting reflecting how strongly each dimension predicts entry success. Score each criterion 1 (weak) to 5 (excellent) , multiply by the weight, and total.
The Seven Dimensions
| Dimension | Weight | Why It Matters |
| 1. Regulatory & Licensing Capability | 20% | Determines whether you can legally operate at all. |
| 2. Compliant Infrastructure & Quality | 20% | Protects product integrity and your regulatory standing. |
| 3. Geographic Coverage & Network | 15% | Determines reach across your target markets. |
| 4. Integration & Operating Model | 15% | Fewer seams = lower risk and coordination cost. |
| 5. Technical & Value-Added Services | 10% | Enables localization and product support. |
| 6. Commercial & Financial Capability | 10% | Determines order-to-cash and risk transfer. |
| 7. Track Record & References | 10% | Evidence of capability under real conditions. |
Dimension 1 — Regulatory & Licensing Capability (Weight ×4)
Dimension 1 — Regulatory & Licensing Capability (Weight ×4)
Score 1–5 on each; average the sub-scores, then apply the weight.
- Can register products with relevant authorities (e.g., HSA Singapore) and conduct pre-assessment studies.
- Holds import and wholesale/distribution licenses appropriate to your product class.
- Covers your target markets (Singapore, Malaysia, Vietnam, Thailand) for regulatory services.
- Can act as authorized representative / importer / distributor where required.
- Handles specialized classes you need (therapeutic, controlled drugs, radioactive/radiopharmaceutical).
Sub-score average: ___ × 4 = ___ / 20
Dimension 2 — Compliant Infrastructure & Quality (Weight ×4)
- Holds relevant certifications (ISO 9001, GDPMDS, ISO 13485, HSA GDP) with scope matching your products.
- Provides the full temperature spectrum you need (ambient → ULT) with redundancy.
- Operates continuous, validated temperature and humidity monitoring with auditable data.
- Maintains segregation, security, access control, and pest management.
- Maintains audit-readiness and supports customer audits.
Sub-score average: ___ × 4 = ___ / 20
Dimension 3 — Geographic Coverage & Network (Weight ×3)
- Presence in your priority markets, not just your first market.
- A regional hub (e.g., Singapore) enabling transshipment / Zero-GST staging.
- Last-mile reach to your customer types (hospitals, institutions, clinics, labs, retail).
- Cross-border capability where your supply chain requires it.
- Capacity to scale with your volume growth.
Sub-score average: ___ × 3 = ___ / 15
Dimension 4 — Integration & Operating Model (Weight ×3)
- Can deliver regulatory + storage + distribution + commercial as one accountable system.
- Offers both 3PL and 4PL models, with a path to evolve between them.
- Minimizes seams/handoffs across the in-market value chain.
- Single point of accountability for outcomes (not just activities).
- Integrated systems (WMS + ERP) provide end-to-end visibility.
Sub-score average: ___ × 3 = ___ / 15
Dimension 5 — Technical & Value-Added Services (Weight ×2)
- Certified relabelling, repackaging, and kitting capability.
- Technical / product support services (e.g., calibration, equipment support) where relevant.
- Post-market support capability.
- E-commerce enablement where your channel mix requires it.
Sub-score average: ___ × 2 = ___ / 10
Dimension 6 — Commercial & Financial Capability (Weight ×2)
- Can perform order management, invoicing, and AR collection (4PL).
- Willing to share/carry inventory and financial risk under agreed terms.
- Provides transparent reporting on stock, orders, and receivables.
- Local commercial presence and terms acceptable to in-market buyers.
Sub-score average: ___ × 2 = ___ / 10
Dimension 7 — Track Record & References (Weight ×2)
- Demonstrable experience with manufacturers and product classes like yours.
- Referenceable customers across relevant sectors (e.g., radiopharma, devices, biologics, diagnostics).
- Evidence of performance under demanding conditions (time-critical, cold chain, surge/pandemic).
- Longevity and stability as an organization.
Sub-score average: ___ × 2 = ___ / 10
Total Score: ___ / 100
|
Total |
Interpretation |
|
85–100 |
Strong fit. A genuinely integrated partner across regulatory, infrastructure, and commercial layers. Proceed to detailed contracting. |
|
70–84 |
Capable, verify gaps. Solid overall; identify which dimension pulled the score down and confirm it is not a binding constraint for your product. |
|
55–69 |
Partial fit. Likely strong in some layers and weak in others — the fragmentation risk. Assess whether the gaps can be closed or must be filled by another provider (adding seams). |
|
Below 55 |
Poor fit. Material gaps in capability or coverage. Continue evaluating alternatives. |
How to Read the Result
The total score matters less than the shape
of the scores. Two principles guide interpretation:
- A low score in Dimension 1 or 2 is disqualifying, regardless of total.
A partner who cannot legally handle your product class, or cannot protect its integrity, fails on a threshold
criterion — no strength elsewhere compensates. - A high total achieved across many separate providers is not the same as a high total from one integrated
partner.
If you assemble a high score by combining a regulatory firm, a warehouse, a transport company, and a commercial
agent, you have also assembled a high
seam count
. Dimension 4 (Integration) exists to capture this: the structural advantage of one accountable system over four
coordinated ones is precisely the advantage that does not show up when you score providers individually.
Use this scorecard early, before commercial discussions narrow your options. A structured partner evaluation,
grounded in evidence rather than impression, is the cheapest insurance available against a market-entry
partnership that fails after product and capital are committed.